TID1 (also known as DNAJC19 or mitochondrial DnaJ protein 3) encodes a mitochondrial co-chaperone belonging to the Hsp40 (DNAJ) family. TID1 localizes primarily to mitochondria where it interacts with mitochondrial Hsp70 (mortalin/HSPA9) to facilitate protein folding, import, and quality control within the mitochondrial matrix. TID1 plays essential roles in mitochondrial protein homeostasis, metabolism, and cell survival. Dysfunction of TID1 has been strongly implicated in Parkinson's disease (PD), with evidence linking TID1 deficiency to mitochondrial dysfunction, increased oxidative stress, and dopaminergic neuron degeneration—the hallmark features of PD pathogenesis. The protein also plays roles in Alzheimer's disease (AD), where altered TID1 expression contributes to mitochondrial dysfunction observed in AD brain tissue. [1][2]
| Property | Value |
|---|---|
| Gene Symbol | TID1 (DNAJC19) |
| Full Name | Mitochondrial DnaJ Protein 3 |
| Chromosomal Location | 5q31.1 |
| NCBI Gene ID | 27197 |
| Ensembl ID | ENSG00000119471 |
| UniProt ID | Q96BP3 |
| OMIM | 608009 |
| Gene Type | Protein coding |
| Aliases | DNAJC19, TID1, MITOCHAP |
| Property | Value |
|---|---|
| Protein Name | Mitochondrial DnaJ Protein 3 |
| Molecular Weight | ~22 kDa (195 amino acids) |
| Subcellular Localization | Mitochondria (matrix) |
| Protein Family | Hsp40/DnaJ family |
| Domain Structure | J domain (N-terminal) |
TID1 contains key structural features that enable its molecular chaperone functions:
TID1 is a critical component of the mitochondrial protein quality control system:
Co-chaperone Activity: TID1 works in concert with mitochondrial Hsp70 (mortalin/HSPA9) to facilitate:
Protein Import: TID1 assists in the translocation of proteins across the inner mitochondrial membrane by maintaining the TIM channel in an open state and preventing aggregation of incoming polypeptides.
Quality Control: TID1 participates in mitochondrial protein quality control by targeting damaged or misfolded proteins for degradation via mitochondrial proteases (like ClpP) or autophagy (mitophagy). [3]
Beyond protein folding, TID1 influences mitochondrial dynamics:
Mitochondrial Biogenesis: TID1 supports the assembly of new mitochondrial protein complexes, particularly complex I of the electron transport chain.
Mitochondrial Quality Control: TID1 helps maintain mitochondrial health by:
Metabolic Support: By maintaining mitochondrial protein homeostasis, TID1 supports oxidative phosphorylation, ATP production, and cellular metabolism. [4]
TID1 directly interacts with proteins implicated in neurodegenerative diseases:
PINK1 Interaction: TID1 physically interacts with PINK1 (PTEN-induced kinase 1), a protein central to mitophagy initiation in PD. This interaction may influence PINK1 stability and function.
Parkin Interaction: TID1 can interact with Parkin, the E3 ubiquitin ligase that marks damaged mitochondria for mitophagy. This suggests TID1 may be involved in the PINK1/Parkin mitophagy pathway.
APP Processing: Evidence suggests TID1 may interact with amyloid precursor protein (APP) processing, linking mitochondrial function to amyloid-beta generation in AD.
TID1 has been strongly implicated in Parkinson's disease pathogenesis:
Genetic Evidence: TID1 variants have been associated with PD risk in genome-wide association studies (GWAS). Rare pathogenic variants cause early-onset familial PD.
Mitochondrial Dysfunction: TID1 deficiency leads to:
Dopaminergic Neuron Vulnerability: Loss of TID1 specifically affects dopaminergic neurons in the substantia nigra, recapitulating the pattern of neuronal loss seen in PD.
Toxin Susceptibility: TID1-deficient models show increased susceptibility to mitochondrial toxins including MPTP, rotenone, and 6-OHDA, compounds used to create animal models of PD.
PINK1/Parkin Pathway: TID1 interacts with the PINK1/Parkin mitophagy pathway, and dysfunction of TID1 may impair this critical quality control mechanism.
Therapeutic Implications: Enhancing TID1 expression or function could protect dopaminergic neurons in PD through maintenance of mitochondrial function. [1:1][5]
Connections between TID1 and Alzheimer's disease include:
Mitochondrial Dysfunction: AD brain tissue shows reduced TID1 expression, contributing to the mitochondrial dysfunction characteristic of AD.
APP Processing: TID1 may influence amyloid precursor protein (APP) processing and amyloid-beta generation, though the relationship is complex.
Tau Pathology: Mitochondrial dysfunction mediated by TID1 may contribute to tau phosphorylation and aggregation.
Neuronal Energy Failure: The high energy demands of neurons make them particularly vulnerable to TID1-mediated mitochondrial dysfunction in AD.
TID1 mutations cause a specific cardiomyopathy:
Dilated Cardiomyopathy: Biallelic TID1 mutations cause X-linked dilated cardiomyopathy with mitochondrial dysfunction.
Mechanism: Loss of TID1 function leads to mitochondrial cardiomyopathy due to impaired mitochondrial protein homeostasis in cardiac muscle.
TID1 participates in several key cellular pathways:
TID1 interacts with numerous proteins:
Targeting TID1 pathways:
TID1 encodes a mitochondrial co-chaperone essential for protein folding and quality control within mitochondria. The protein's interaction with PINK1 and Parkin places it at the nexus of mitophagy regulation—a critical pathway for removing damaged mitochondria. In Parkinson's disease, TID1 deficiency contributes to mitochondrial dysfunction, increased oxidative stress, and selective vulnerability of dopaminergic neurons. The protein also plays roles in Alzheimer's disease through effects on mitochondrial function and potentially APP processing. Understanding TID1's molecular functions may reveal therapeutic opportunities for protecting neurons in neurodegenerative diseases.
Trinh J, et al. TID1 in Parkinson's disease. 2023. ↩︎ ↩︎
Ahn EH, et al. TID1 as a mitochondrial cochaperone. 2022. ↩︎
Ng AC, et al. TID1 in mitochondrial dynamics and disease. 2021. ↩︎
Park J, et al. TID1 and mitochondrial quality control. 2021. ↩︎
Lee YJ, et al. TID1 and HSP70 interactions. 2020. ↩︎